Vantage Investment Partners LLC raised its holdings in Centene Co. (NYSE:CNC – Free Report) by 17.1% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 683,817 shares of the company’s stock after buying an additional 99,904 shares during the period. Centene makes up approximately 4.3% of Vantage Investment Partners LLC’s portfolio, making the stock its 4th largest position. Vantage Investment Partners LLC owned 0.14% of Centene worth $51,478,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in CNC. Swedbank AB acquired a new position in shares of Centene during the first quarter worth about $914,080,000. Boston Partners boosted its holdings in shares of Centene by 0.4% in the 1st quarter. Boston Partners now owns 8,652,177 shares of the company’s stock valued at $678,033,000 after purchasing an additional 32,427 shares during the last quarter. Bank of New York Mellon Corp boosted its holdings in shares of Centene by 0.5% in the 2nd quarter. Bank of New York Mellon Corp now owns 5,491,968 shares of the company’s stock valued at $364,117,000 after purchasing an additional 25,595 shares during the last quarter. Capital International Investors raised its stake in shares of Centene by 60.2% in the 1st quarter. Capital International Investors now owns 5,216,486 shares of the company’s stock valued at $409,390,000 after acquiring an additional 1,959,460 shares during the period. Finally, Legal & General Group Plc raised its stake in shares of Centene by 14.2% in the 2nd quarter. Legal & General Group Plc now owns 5,113,759 shares of the company’s stock valued at $339,042,000 after acquiring an additional 636,683 shares during the period. Hedge funds and other institutional investors own 93.63% of the company’s stock.
Analysts Set New Price Targets
Several equities research analysts have recently weighed in on the stock. Deutsche Bank Aktiengesellschaft boosted their target price on shares of Centene from $82.00 to $87.00 and gave the stock a “hold” rating in a research report on Friday, August 2nd. Cantor Fitzgerald reiterated an “overweight” rating and issued a $90.00 price objective on shares of Centene in a report on Tuesday, October 1st. Wells Fargo & Company decreased their price objective on shares of Centene from $91.00 to $90.00 and set an “overweight” rating for the company in a report on Monday, November 4th. Barclays cut their target price on shares of Centene from $97.00 to $91.00 and set an “overweight” rating for the company in a research note on Tuesday, October 29th. Finally, Truist Financial reduced their price target on shares of Centene from $92.00 to $89.00 and set a “buy” rating for the company in a research report on Monday, July 15th. Seven equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $83.92.
Insider Transactions at Centene
In other Centene news, CEO Sarah London acquired 4,117 shares of the company’s stock in a transaction that occurred on Friday, November 8th. The stock was acquired at an average price of $60.80 per share, for a total transaction of $250,313.60. Following the acquisition, the chief executive officer now directly owns 667,229 shares in the company, valued at $40,567,523.20. This represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 0.33% of the company’s stock.
Centene Trading Up 1.0 %
CNC stock opened at $60.75 on Tuesday. Centene Co. has a 52 week low of $59.77 and a 52 week high of $81.42. The company’s 50-day simple moving average is $69.71 and its 200 day simple moving average is $71.52. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.10 and a current ratio of 1.10. The company has a market capitalization of $30.67 billion, a PE ratio of 10.55, a price-to-earnings-growth ratio of 0.82 and a beta of 0.49.
About Centene
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.
Further Reading
- Five stocks we like better than Centene
- How to Most Effectively Use the MarketBeat Earnings Screener
- 2 Chip Stocks Benefitting from OpenAI’s Chip Strategy Expansion
- Earnings Per Share Calculator: How to Calculate EPS
- Monday.com’s Manic Price Pullback Is a Signal to Buy
- How to Buy Cheap Stocks Step by Step
- 3 “Made in America” Stocks to Benefit From the Trump Presidency
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.